Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence-Reference-Cited by-同舟云学术

Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence

Published:2022 Issue:11 Volume:23 Page:1089
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Kim Nari¹²^ORCID,Lee Eun Sung¹²^ORCID,Won Sang Eun¹²^ORCID,Yang Mihyun¹²^ORCID,Lee Amy Junghyun¹²^ORCID,Shin Youngbin¹²^ORCID,Ko Yousun¹²^ORCID,Pyo Junhee¹^ORCID,Park Hyo Jung²^ORCID,Kim Kyung Won¹²^ORCID

Affiliation:

1. Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

The Korean Society of Radiology

Subject

Radiology, Nuclear Medicine and imaging

Link

https://kjronline.org/pdf/10.3348/kjr.2022.0225

Reference51 articles.

1. Imaging of Precision Therapy for Lung Cancer: Current State of the Art

2. Assessing Immunotherapy with Functional and Molecular Imaging and Radiomics